In our study, methylation of the WIF1 promoter was detected in 63% of invasive tumors from breast cancer patients, thus being in good agreement with previous results from Ai et al. [11], who reported a frequency of 67% for WIF1 methylation in mammary tumors. The gene discussed is WIF1; the disease is breast cancer.